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ABSTRACT 
Serous tumors constitute about 25% of all ovarian tumors. Serous adenocarcinomas are the commonest form of the malignant 
epithelial ovarian tumors accounting for 26% of the cases. The commonest morphologic form is the cystadenocarcinoma. 
Serous surface papillary adenocarcinoma is a very rare morphologic entity which is often bilateral and highly aggressive. 
Reports showing an exact incidence are not available in literature. We present a case of serous surface papillary 
adenocarcinoma confined to ovary. 
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erous tumors constitute about 25% of all ovarian 
tumors [1].
 
Serous adenocarcinomas are the 
commonest form of the malignant epithelial ovarian 
tumors accounting for 26% of the cases in the Unites 
States [2]. The commonest morphologic form is the 
cystadenocarcinoma with or without surface involvement. 
Serous surface papillary adenocarcinoma (without the 
cystic component) (SSPC) is a very rare morphologic 
entity which is often bilateral and highly aggressive [3,4]. 
Reports related to this neoplasm are rare and its exact 
incidence has not been documented in literature. The 
number of serous ovarian tumors reported in our hospital 
from 2007 to 2011 (5 year period) constituted 22 benign, 3 
borderline and 6 malignant cases; out of which, only 1 
belonged to the category of SSPC. 
CASE REPORT 
A 60 year old female presented with abdominal distension 
due to ascites for which ascitic tap was done which was 
positive for malignant cells. An ultrasound (USG) showed  
 
bilateral ovarian enlargement. The patient was otherwise in 
good health. A radical hysterectomy was done. CA-125 
estimation was not done for the patient. As patient 
belonged to lower socioeconomic group and histology was 
consistent with its primary origin and patient had no other 
clinical findings or suspicion of malignancy elsewhere, 
IHC work up was also not done. 
On gross pathologic examination, uterus, cervix and 
both tubes appeared normal. Both the ovaries were 
enlarged and measured 6x5x4cms and 5x3x2cms. Their 
surface was studded all over with extensive papillary 
excrescences (Fig 1). On cytological examination, ascitic 
fluid showed loose sheets of large, pleomorphic, 
hyperchromatic cells with irregular nuclear contours and 
moderate amount of cytoplasm arranged singly and in 
clusters (Fig.2). On histopathology examination, 
microscopy showed papillary fronds with numerous 
fibrovascular cores covered by multiple layers of highly 
pleomorphic epithelial cells with vesicular nuclei and one 
to two nucleoli. Prominent stromal invasion was observed. 
These findings confirmed the diagnosis as SSPC. 
S 
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Figures - Fig. 1: Bilateral ovarian masses showing multiple papillary excrescences over the entire surface. Fig. 2: Uninvolved 
Fallopian tubes. Fig. 3: Cut surface of the left ovarian mass. Note absence of cystic component. 
       
Figure 4 - Giemsa stain. A: High power view (X400). B: Lower power view. C: Low power view. 
     
Figure 5 - A: Low power view shows surface papillary fronds covered by multilayered neoplastic cells and foci of stromal 
invasion (arrow). B: A high power view (H&E X400) on one of the papillae. 
DISCUSSION 
Serous surface papillary carcinoma is a distinct type of 
ovarian cancer. As per reports in literature, most patients 
present with extensive intra-abdominal disease at the time 
of diagnosis. This may be in the form of peritoneal 
carcinomatosis with a highly elevated serum CA-125 level. 
The ovaries may not be markedly enlarged [5].
 
Kim et al 
also showed that SSPC has macroscopic normal ovaries 
accompanied by diffuse peritoneal dissemination due to 
which it cannot be usually diagnosed preoperatively.  
USG, CT, and MRI findings demonstrating 
nodularities along the surface of normal-sized ovaries, 
adjacent organs and pelvic peritoneum along with 
peritoneal seedings may suggest the correct preoperative 
diagnosis of SSPC [6]. In our case, USG showed only 
enlarged bilateral ovaries and no other findings. They may 
also present with systemic lymphadenopathy but without 
any evidence of intra-abdominal disease [7]. 
SSPC and peritoneal papillary serous cancers have 
common histologic appearance and are considered as part 
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of a disease spectrum and show a similar responsiveness to 
surgical therapy as well as chemotherapy and should be 
treated similarly [8].
 
On the contrary, Kim et al has 
mentioned that SSPC should be differentiated from other 
unresponsive cases of peritoneal carcinomatosis as it has a 
better response to surgical response followed by 
chemotherapy [5]. Mulhollan et al has mentioned SSPC as 
a multicentric peritoneal tumor that can spare or minimally 
involve ovaries and are more aggressive than the usual 
form of serous carcinoma of ovary [9]. Studies have shown 
that SSPC can be associated with coexistent, non-
peritoneal, serous-type carcinomas; superficial endometrial 
adenocarcinomas; and intramucosal adenocarcinoma of the 
fallopian tube [9]. 
Role of IHC has been emphasized in differentiating 
primary serous ovarian carcinoma from metastatic 
colorectal adenocarcinoma to ovary suggesting CK7 to be 
the most helpful marker which is extensively positive in 
primary carcinoma. CK20 and CEA are also of value to 
differentiate serous ovarian which are generally negative 
from colorectal adenocarcinomas [10]. Studies have shown 
that immunohistochemistry does not help in separating 
papillary serous carcinomas of the peritoneum from serous 
carcinomas of the ovary [11]. 
In the 5 year period from 2007 to 2011, SSPC was seen 
only in 1 of the 31 cases of serous epithelial tumors 
accounting for 3.22% cases observed at the department of 
pathology in our hospital. Our case differed from those 
reported in the literature with regard to their confinement 
to the ovary and the absence of lymphadenopathy and 
other coexistent malignancy. 
CONCLUSION 
Serous surface papillary carcinoma is a rare morphologic 
entity of the serous epithelial tumors and high index of 
suspicion is required to diagnosis it correctly. 
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